Type I interferons in host defence and inflammatory diseases
Open Access
- 17 May 2019
- journal article
- review article
- Published by BMJ in Lupus Science & Medicine®
- Vol. 6 (1), e000336
- https://doi.org/10.1136/lupus-2019-000336
Abstract
Type I interferons (IFN) can have dual and opposing roles in immunity, with effects that are beneficial or detrimental to the individual depending on whether IFN pathway activation is transient or sustained. Determinants of IFN production and its functional consequences include the nature of the microbial or nucleic acid stimulus, the type of nucleic acid sensor involved in inducing IFN, the predominant subtype of type I IFN produced and the immune ecology of the tissue at the time of IFN expression. When dysregulated, the type I IFN system drives many autoimmune and non-autoimmune inflammatory diseases, including SLE and the tissue inflammation associated with chronic infection. The type I IFN system may also contribute to outcomes for patients affected by solid cancers or myocardial infarction. Significantly more research is needed to discern the mechanisms of induction and response to type I IFNs across these diseases, and patient endophenotyping may help determine whether the cytokine is acting as ‘friend’ or ‘foe’, within a particular patient, and at the time of treatment. This review summarises key concepts and discussions from the second International Summit on Interferons in Inflammatory Diseases, during which expert clinicians and scientists evaluated the evidence for the role of type I IFNs in autoimmune and other inflammatory diseases.Keywords
Funding Information
- AstraZeneca
This publication has 138 references indexed in Scilit:
- Prevalence of interferon type I signature in CD14 monocytes of patients with Sjögren's syndrome and association with disease activity and BAFF gene expressionAnnals Of The Rheumatic Diseases, 2012
- Programmed Death Ligand 2 in Cancer-Induced Immune SuppressionClinical and Developmental Immunology, 2012
- Toll-like receptors: key players in antiviral immunityCurrent Opinion in Virology, 2011
- An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosisNature, 2010
- Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and toleranceImmunological Reviews, 2010
- Association of the response to tumor necrosis factor antagonists with plasma type I interferon activity and interferon‐β/α ratios in rheumatoid arthritis patients: A post hoc analysis of a predominantly Hispanic cohortArthritis & Rheumatism, 2010
- Global genomic analysis reveals rapid control of a robust innate response in SIV-infected sooty mangabeysJCI Insight, 2009
- An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancerProceedings of the National Academy of Sciences of the United States of America, 2008
- The role of type I interferon production by dendritic cells in host defenseBiochimie, 2007
- Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patientsAnnals Of The Rheumatic Diseases, 2007